Expertise in
30
conditions

Dr. Andrew E. Sloan

Neurosurgery
Clinical Neuroscience Institute At Miami Valley Hospital South Campus
2300 Miami Valley Dr Ste 550, 
Centerville, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
30
conditions
Clinical Neuroscience Institute At Miami Valley Hospital South Campus
2300 Miami Valley Dr Ste 550, 
Centerville, OH 

Overview

Andrew Sloan is a Neurosurgery provider practicing medicine in Centerville, Ohio.

Dr. Sloan is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery.

He is actively involved in clinical research, co-authoring 181 peer reviewed articles and participating in 9 clinical trials. Dr. Sloan is currently accepting new patients.

Specialties

Neurosurgery

Licenses

Neurological Surgery in OH

Hospital Affiliations

Upper Valley Medical Center
Miami Valley Hospital

Languages Spoken

English
Haitian Creole
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Clinical Neuroscience Institute at Miami Valley Hospital South Campus
2300 Miami Valley Dr Ste 550, Centerville, OH 45459
Other Locations
Clinical Neuroscience Institute at Miami Valley Hospital
30 E Apple St Ste 5254, Dayton, OH 45409

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis
Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis
Enrollment Status: Recruiting
Publish Date: November 21, 2025
Intervention Type: Radiation, Drug, Biological
Study Drugs: P140K-MGMT, O6-benzylguanine, Temozolomide, Filgrastim, Carmustine
Study Phase: Phase 2
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Safety and Efficacy of IGV-001, an Autologous Cell Immunotherapy With Antisense Oligonucleotide (IMV-001) Targeting IGF-1R, in Newly Diagnosed Patients With Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2026
Intervention Type: Combination product, Procedure, Drug
Study Drugs: IGV-001 Cell Immunotherapy, Temozolomide
Study Phase: Phase 2
Phase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Phase I/II Study of Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2026
Intervention Type: Procedure, Drug
Study Drug: Pembrolizumab
Study Phase: Phase 1/Phase 2
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
A Multicenter Phase 2 Study of Oncolytic Polio/Rhinovirus Recombinant (Lerapolturev) in Recurrent WHO Grade IV Malignant Glioma Patients
Enrollment Status: Completed
Publish Date: July 11, 2025
Intervention Type: Biological, Drug
Study Drug: Oncolytic Polio/Rhinovirus Recombinant Vaccine
Study Phase: Phase 2
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
A Phase 2, Open-label, Single-arm Study Evaluating the Efficacy, Safety and Tolerability of Lerapolturev (PVSRIPO) and the Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: June 05, 2025
Intervention Type: Biological
Study Drugs: PVSRIPO, Pembrolizumab
Study Phase: Phase 2
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
Enrollment Status: Completed
Publish Date: April 24, 2025
Intervention Type: Device
A Prospective Phase II Trial of NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
A Prospective Phase II Trial of NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: February 17, 2025
Intervention Type: Biological, Device, Other
Study Phase: Phase 2
06-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients With MGMT Positive Tumors With Infusion of Autologous P140KMGMT+ Hematopoietic Progenitors to Protect Hematopoiesis
06-benzylguanine (BG) and Temozolomide (TMZ) Therapy of Glioblastoma Multiforme (GBM) in Patients With MGMT Positive Tumors With Infusion of Autologous P140KMGMT+ Hematopoietic Progenitors to Protect Hematopoiesis
Enrollment Status: Completed
Publish Date: March 02, 2023
Intervention Type: Biological, Procedure, Other, Radiation, Drug
Study Drugs: MGMTP140K-encoding retroviral vector, O6-benzylguanine, Temozolomide
Study Phase: Phase 1
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 8 Less Clinical Trials

181 Total Publications

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 17, 2026
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (39.2 miles away)
513-636-4726
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Francesco Mangano is a Neurosurgery provider practicing medicine in Cincinnati, Ohio. Dr. Mangano is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Cortical Dysplasia, Chiari Malformation, Posterior Fossa Decompression, and Rhizotomy. Dr. Mangano is currently accepting new patients.

Expertise in
18
conditions
Dr. Owoicho Adogwa
Neurosurgery
Expertise in
18
conditions
Dr. Owoicho Adogwa
Neurosurgery
Referral may be required

University Of Cincinnati Physicians Company LLC

3113 Bellevue Ave, 
Cincinnati, OH 
 (39.6 miles away)
513-475-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Owoicho Adogwa is a Neurosurgery provider practicing medicine in Cincinnati, Ohio. Dr. Adogwa is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Spondylolisthesis, Spinal Stenosis, Scoliosis, Spinal Fusion, and Laminectomy. Dr. Adogwa is currently accepting new patients.

Expertise in
33
conditions
Dr. Ronald E. Warnick
Neurosurgery | Oncology | Radiation Oncology
Expertise in
33
conditions
Dr. Ronald E. Warnick
Neurosurgery | Oncology | Radiation Oncology
Referral may be required

Mayfield Brain & Spine

3825 Edwards Road, Suite 300, 
Cincinnati, OH 
 (36.8 miles away)
513-221-1100
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ronald Warnick, MD is a neurosurgeon practicing at TriHealth. Dr. Warnick is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Meningioma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Gamma Knife Radiosurgery, and Endovascular Embolization. Dr. Warnick is board certified in American Board Of Neurological Surgery and American Board Of Neurological Surgery - 1995. Dr. Warnick is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew E. Sloan

How do I make an appointment with Dr. Andrew E. Sloan?

You can book an appointment with Dr. Andrew E. Sloan by calling their office at 937-668-7219. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew E. Sloan a top-rated expert for Glioblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew E. Sloan is classified as an Elite expert for Glioblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew E. Sloan specialize in?

While Dr. Andrew E. Sloan is a Neurosurgery, they have specific expertise in Glioblastoma, Astrocytoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurosurgery.

Does Dr. Andrew E. Sloan participate in research or clinical trials?

Yes. Dr. Andrew E. Sloan has published 181 articles and abstracts on conditions like Glioblastoma. You can view a list of Dr. Andrew E. Sloan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew E. Sloan accept my insurance?

Dr. Andrew E. Sloan accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 937-668-7219 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sloan's expertise for a condition
ConditionClose
View All 15 Distinguished Conditions
View All 9 Advanced Conditions
View All 39 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile